Cargando…

Current role of Pipelle endometrial sampling in early diagnosis of endometrial cancer

Endometrial cancer is the most common gynecologic cancer in developed countries. The most prevalent, however not pathognomonic symptom of the disease is abnormal uterine bleeding. The diagnosis of endometrial cancer is based on the histologic results of endometrial sampling. Endometrial biopsy could...

Descripción completa

Detalles Bibliográficos
Autores principales: Terzic, Milan Milosav, Aimagambetova, Gulzhanat, Terzic, Sanja, Norton, Melanie, Bapayeva, Gauri, Garzon, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798375/
https://www.ncbi.nlm.nih.gov/pubmed/35117374
http://dx.doi.org/10.21037/tcr.2020.04.20
_version_ 1784641790029070336
author Terzic, Milan Milosav
Aimagambetova, Gulzhanat
Terzic, Sanja
Norton, Melanie
Bapayeva, Gauri
Garzon, Simone
author_facet Terzic, Milan Milosav
Aimagambetova, Gulzhanat
Terzic, Sanja
Norton, Melanie
Bapayeva, Gauri
Garzon, Simone
author_sort Terzic, Milan Milosav
collection PubMed
description Endometrial cancer is the most common gynecologic cancer in developed countries. The most prevalent, however not pathognomonic symptom of the disease is abnormal uterine bleeding. The diagnosis of endometrial cancer is based on the histologic results of endometrial sampling. Endometrial biopsy could be obtained using different modalities: hysteroscopy-directed endometrial biopsy, uterine curettage or office endometrial biopsy. Outpatient endometrial biopsy using different devices for the evaluation of abnormal uterine bleeding is gaining popularity. The most popular office-based device for endometrial sampling procedure is the Pipelle device. Currently, Pipelle endometrial sampling is widely used to diagnose endometrial cancer in women with abnormal uterine bleeding and/or postmenopausal bleeding. The method became very useful due to easiness and simplicity of the procedure, availability of a device, as well as high sensitivity in detecting endometrial cancer. Many studies compared the validity and accuracy of Pipelle biopsy with dilation and curettage in the detection of various endometrial pathologies. Published results state that Pipelle biopsy and uterine curettage are almost equally reliable in the evaluation of endometrial pathologies. Moreover, Pipelle biopsy appears more beneficial as it does not require hospital admission and anaesthesia. However, it is proven the Pipelle technique has a limited capacity to identify endometrial polyps, and some authors, based on their study, claim that dilation and curettage is a more reliable method in terms of correlation with the final histological results. In addition, there are many factors affecting the efficiency of the endometrial biopsy. Failure to get samples that are adequate for histological examination is one of the problems associated with Pipelle sampling. The above mentioned contradictory conclusions by different researchers and lack of guidance to avoid inadequate sampling present the demand for further studies on the comparison of Pipelle biopsy and uterine curettage efficiency and accuracy.
format Online
Article
Text
id pubmed-8798375
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87983752022-02-02 Current role of Pipelle endometrial sampling in early diagnosis of endometrial cancer Terzic, Milan Milosav Aimagambetova, Gulzhanat Terzic, Sanja Norton, Melanie Bapayeva, Gauri Garzon, Simone Transl Cancer Res Review Article on Endometrial Cancer Endometrial cancer is the most common gynecologic cancer in developed countries. The most prevalent, however not pathognomonic symptom of the disease is abnormal uterine bleeding. The diagnosis of endometrial cancer is based on the histologic results of endometrial sampling. Endometrial biopsy could be obtained using different modalities: hysteroscopy-directed endometrial biopsy, uterine curettage or office endometrial biopsy. Outpatient endometrial biopsy using different devices for the evaluation of abnormal uterine bleeding is gaining popularity. The most popular office-based device for endometrial sampling procedure is the Pipelle device. Currently, Pipelle endometrial sampling is widely used to diagnose endometrial cancer in women with abnormal uterine bleeding and/or postmenopausal bleeding. The method became very useful due to easiness and simplicity of the procedure, availability of a device, as well as high sensitivity in detecting endometrial cancer. Many studies compared the validity and accuracy of Pipelle biopsy with dilation and curettage in the detection of various endometrial pathologies. Published results state that Pipelle biopsy and uterine curettage are almost equally reliable in the evaluation of endometrial pathologies. Moreover, Pipelle biopsy appears more beneficial as it does not require hospital admission and anaesthesia. However, it is proven the Pipelle technique has a limited capacity to identify endometrial polyps, and some authors, based on their study, claim that dilation and curettage is a more reliable method in terms of correlation with the final histological results. In addition, there are many factors affecting the efficiency of the endometrial biopsy. Failure to get samples that are adequate for histological examination is one of the problems associated with Pipelle sampling. The above mentioned contradictory conclusions by different researchers and lack of guidance to avoid inadequate sampling present the demand for further studies on the comparison of Pipelle biopsy and uterine curettage efficiency and accuracy. AME Publishing Company 2020-12 /pmc/articles/PMC8798375/ /pubmed/35117374 http://dx.doi.org/10.21037/tcr.2020.04.20 Text en 2020 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Review Article on Endometrial Cancer
Terzic, Milan Milosav
Aimagambetova, Gulzhanat
Terzic, Sanja
Norton, Melanie
Bapayeva, Gauri
Garzon, Simone
Current role of Pipelle endometrial sampling in early diagnosis of endometrial cancer
title Current role of Pipelle endometrial sampling in early diagnosis of endometrial cancer
title_full Current role of Pipelle endometrial sampling in early diagnosis of endometrial cancer
title_fullStr Current role of Pipelle endometrial sampling in early diagnosis of endometrial cancer
title_full_unstemmed Current role of Pipelle endometrial sampling in early diagnosis of endometrial cancer
title_short Current role of Pipelle endometrial sampling in early diagnosis of endometrial cancer
title_sort current role of pipelle endometrial sampling in early diagnosis of endometrial cancer
topic Review Article on Endometrial Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798375/
https://www.ncbi.nlm.nih.gov/pubmed/35117374
http://dx.doi.org/10.21037/tcr.2020.04.20
work_keys_str_mv AT terzicmilanmilosav currentroleofpipelleendometrialsamplinginearlydiagnosisofendometrialcancer
AT aimagambetovagulzhanat currentroleofpipelleendometrialsamplinginearlydiagnosisofendometrialcancer
AT terzicsanja currentroleofpipelleendometrialsamplinginearlydiagnosisofendometrialcancer
AT nortonmelanie currentroleofpipelleendometrialsamplinginearlydiagnosisofendometrialcancer
AT bapayevagauri currentroleofpipelleendometrialsamplinginearlydiagnosisofendometrialcancer
AT garzonsimone currentroleofpipelleendometrialsamplinginearlydiagnosisofendometrialcancer